Bertrand NADEL
PhD
-
Leader of the team "Genomic instability and human hemopathies" at the CIML | Institut Carnot CALYM Director | Former Director of the Canceropole PACA
CIML, Institut Carnot CALYM, Cancéropole PACA
A therapeutic revolution is happening.
Cancéropôle PACA joins forces with Marseille-Immunopôle to the fight against cancer, through the structuration of ground-breaking platforms and the support of ambitious and strategic academic and translational research programs in the field of anti-tumoral immunotherapy.
A therapeutic revolution is happening.
#clinique #rechercheHave a look on our testimonies
MI COMMUNITY
Each year, a large number of clinical trials are conducted by APHM clinicians alone or in partnership with industry players in biopharmaceuticals.
Frédéric VELY
AMU, AP-HM, CIML
MI COMMUNITY
MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.
Delphine BADINAND
APHM
MI COMMUNITY
Education is also one of the strategic components of the Marseille Immunopole project.
Françoise DIGNAT-GEORGE
AMU, AP-HM, C2VN
MI COMMUNITY
Our aim is simple: to position ourselves upstream of the diagnosis and to propose innovative treatments to patients
Emmanuelle CHARAFE-JAUFFRET
AMU, IPC, CRCM
MI AND YOU Show
your commitment to MI
your commitment to MI